Mirae Asset Global Investments
HUMA icon

Mirae Asset Global Investments’s Humacyte HUMA Stock Holding History

Mirae Asset Global Investments’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.75K Sell
9,930
-137
-1% -$127 ﹤0.01% 1597
2026
Q1 		$6.11K Buy
10,067
+967
+11% +$1K ﹤0.01% 1524
2025
Q4 		$8.74K Buy
9,100
+2,977
+49% +$4.22K ﹤0.01% 1608
2025
Q3 		$10.7K Buy
6,123
+131
+2% +$257 ﹤0.01% 1570
2025
Q2 		$12.5K Buy
5,992
+1,856
+45% +$3.57K ﹤0.01% 1461
2025
Q1 		$8.11K Sell
4,136
-152
-4% -$571 ﹤0.01% 1488
2024
Q4 		$23.6K Sell
4,288
-29
-0.7% -$143 ﹤0.01% 1397
2024
Q3 		$24.1K Buy
4,317
+762
+21% +$5.02K ﹤0.01% 1408
2024
Q2 		$16.7K Buy
+3,555
New +$18.5K ﹤0.01% 1407

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return
LWM
LJI Wealth Management Indianapolis, Indiana $714M AUM 21.51% 1-Year Est. Return
UAS
United Asset Strategies Garden City, New York $1.41B AUM 27.73% 1-Year Est. Return
EWM
Endowment Wealth Management Appleton, Wisconsin $259M AUM 15.06% 1-Year Est. Return

Mirae Asset Global Investments's HUMA Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Humacyte (HUMA) stake by 1.4% in Q2 2026, selling an estimated $127 and leaving 9,930 shares worth $7.75K. The position accounts for ﹤0.01% of the portfolio, ranked #1597.

Mirae Asset Global Investments first reported a position in HUMA in Q2 2024 and has held it in 9 quarters since. The position peaked at $24.1K in Q3 2024. 66 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Mirae Asset Global Investments held 9,930 shares of Humacyte worth $7.75K as of Q2 2026.
  • Mirae Asset Global Investments sold 137 Humacyte shares in Q2 2026, an estimated $127.
  • Humacyte made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1597 holding.
  • Mirae Asset Global Investments first reported a position in Humacyte in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global Investments's Humacyte position peaked at $24.1K in Q3 2024.
  • 66 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.